MIRA's Ketamir-2 shows promise in treating diabetic neuropathy, with a Phase 2a trial expected by late 2025 and human data in ...

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on dosing, data on a ketamine ...

MIRA Pharmaceuticals (MIRA) announced data demonstrating the efficacy of the oral ketamine analog, Ketamir-2, in a validated animal model of ...

Ketamir-2 Demonstrates Strong Efficacy in Diabetic Neuropathy Model, with Some Subjects Achieving Complete Symptom Reversal MIAMI, FLORIDA / ACCESS Newswire / April 16, 2025 / MIRA Pharmaceuticals, ...

A research paper by scientists at The Second Affiliated Hospital of Zhejiang University School of Medicine presented the ...

A research paper by scientists at The Second Affiliated Hospital of Zhejiang University School of Medicine presented the ...

Juice in streptozotocin -induced diabetic rats, bottle gourd has a lot of health advantages and can be used as a treatment for several conditions, including cancer, piles, diabetes, flatulence ...

A research paper by scientists at The Second Affiliated Hospital of Zhejiang University School of Medicine presented the application of Ultrasound ...

MIRA READ THE FULL MIRA RESEARCH REPORT MIRA Pharmaceuticals (NASDAQ:MIRA) is a clinical-stage pharmaceutical company focused on the development and commercialization of a new molecular synthetic ...

(MD) graduated from Geneva Medical School in 1989 and was a Research and Clinical Fellow and Lecturer in Medicine at Harvard Medical School from 1997-2001. He has received a professorship grant from ...